AzTrials
AzTrials

Imposter SyndromeNCT05732792

Survey Evaluating the Prevalence and the Severity of Feelings of Self-doubt in European Anesthesiologists

An observational study of Imposter Syndrome and Anesthesia, run by Université Libre de Bruxelles at 1 site in Belgium.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Impostor syndrome is a form of erroneous self-assessment that is defined as the inability to believe that one's success is earnt and that positive outcomes are the result of one's skills. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Imposter Syndrome, Anesthesia
What is being tested?
CIPS Survey
How many people
700 participants
Where
1 siteBelgium
Study dates
11 Feb 2023to 14 May 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The survey is endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) and will be distributed from February 2023 onwards to its members for a period of 3 months.

Who may be able to join

  • Anesthesiologists

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • AZ Sint-Jan Brugge Oostende AV

    Bruges

Other trials in Belgium

About this study

Impostor syndrome is a form of erroneous self-assessment that is defined as the inability to believe that one's success is earnt and that positive outcomes are the result of one's skills.

The syndrome has been described and studied in an array of different populations including the healthcare setting and academic faculty members working in a competitive environment. A scoping review of the imposter syndrome in physicians and physicians in training concluded that low self-esteem, gender, and institutional culture are linked to high rates of imposter syndrome. The fact that this syndrome has been linked to higher rates of burnout is more worrisome. Moreover, this specific syndrome might prevent physicians from acting in certain situations.

Read more

Even though Impostor syndrome has been described in doctors across a wide range of specialties, it has yet to be specifically investigated within anesthesiology. We hypothesize that imposter syndrome prevalence will be high in this population due to core attributes of the profession itself.

With this study, the prevalence and severity of imposter syndrome in the European anesthesia profession will be investigated by using the Clance Impostor Phenomenon Scale (CIPS) scale, which will be completed by anesthesiologists and anesthesiology residents members of the European Society of Anesthesiology and Intensive Care.

In parallel, key demographics that are linked to increased severity of the imposter syndrome will also be investigated.

Read the detailed description

Imposter syndrome is a difficult to grasp concept. Clance and Imes have been the first to label "the inability to internalize success and the tendency to attribute success to external causes such as luck, error or knowing the appropriate individuals" as 'imposter syndrome'. This concept stemmed from the qualitative observation of high achieving women in 1978. Imposter syndrome might be triggered by anxiety, perfectionism, and self-doubt.

Since then, the syndrome has been better described and studied in an array of different populations including academic faculty members in a competitive environment and the healthcare setting. A scoping review of the imposter syndrome in physicians and physicians in training concluded that low self-esteem, gender, and institutional culture are linked to high rates of imposter syndrome. A recent survey study from Villock et al. explored the rate of imposter syndrome and burnout among American medical students and recognized that about half of the female students and a quarter of the male students experience imposter syndrome. Studies in surgery residents, with a response rate of 47%, found that more than three quarter were either significantly or severely affected by the imposter syndrome. Surgery residents are more prone to imposter syndrome than trained ones. More worrisome is the link to burnout.

Most of the studies mentioned used the Clance imposter phenomenon scale (CIPS) to explore the prevalence of imposter syndrome in the population of choice. The CIPS have been validated and used since 1995.

No study has yet explored imposter syndrome among anesthesiologists, though imposter syndrome prevalence might be high in this population due to core attributes of the profession itself. These attributes are likely to depend on the environment in which anesthesiologists evolve. However, performance in clinical work and skills, great interpersonal qualities such as communication skills and good relationship with patients and colleagues are required to excel in our profession. Some of these personal skills have yet to be taught to anesthesiology residents, endorsing imposter syndrome symptoms.

The prevalence and severity of the imposter syndrome in the European anesthesia profession will be studied by using the CIPS scale in anesthesiologists and anesthesiology residents. In parallel, key demographics that are linked to increased severity of the imposter syndrome will be investigated.

Aims The primary aim of this study is to define the prevalence and severity of imposter syndrome among anesthesiologists, which has never been evaluated on a large scale.

The secondary aim of the present study is to identify risk factors associated with imposter syndrome (Gender, age, level of experience, working country, ethnicity, academic work, main activity).

Being tested
CIPS Survey
Medical subject headings
imposter syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CIPS SurveyOther

    The survey is endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) and will be distributed from February 2023 onwards to its members for a period of 3 months.

    Each anesthesiologist's participation to the survey will be voluntary and anonymous individual consent will be implied by the person's willingness to complete the survey.

    The survey will also mention this.

    All surveys will be administered via SurveyMonkey. Surveymonkey allows to build "Health Insurance Portability and Accountability Act" (HIPAA) compliant surveys that follow strict rules around the protection of health information.

    Of note, Surveymonkey is also GDPR (General Data Protection Regulation) compliant.

    Data gathered from the questionnaires will be safely stored on the surveymonkey database. The access to the result database is held by a password that only the authors can use to analyze the data yielded at the end of the survey period.

Study groups in NCT05732792
Study groupRoleWhat they receive
Anesth-CIPSThe survey is endorsed by the European Society of Anaesthesiology and Intensive Care (ESAIC) and will be distributed from February 2023 onwards to its members for a period of 6 months.
Receives: Other: CIPS Survey

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. CIPS

    The primary aim of this study is to define the prevalence and severity of imposter syndrome among anesthesiologists, which has never been evaluated on a large scale. This will be done through CIPS (Clance Imposter Phenomenon Scale) score.

    (CIPS is a previously validated survey consisting of 20 questions on a 5-point Likert scale that investigate feelings about self-assessment of competency, praise, and success. Levels of severity of imposter syndrome have been described previously. Briefly, if the total score is 40 or less, the respondent has few Impostor characteristics; if the score is between 41 and 60, the respondent has moderate IP experiences; a score between 61 and 80 means the respondent frequently has Impostor feelings; a score higher than 80 means the respondent often has intense IP experiences. The higher the score, the more frequently and seriously the Impostor Phenomenon interferes in a person's life.

    Measured: 3 months

Secondary outcomes (1)
  1. Risk factors IP-anesthesia

    The secondary aim of the present study is to identify risk factors associated with imposter syndrome (Gender, age, level of experience, working country, ethnicity, academic work, main activity).

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2023
  2. Study start11 Feb 2023
  3. Primary completion11 May 2023
  4. Study completion14 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
700 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05732792
Sponsor's protocol ID
AnesthesiaCIPS
Status last verified
Jul 2023
First submitted
8 Feb 2023
Last updated
21 Jul 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Imposter Syndrome and Anesthesia, run by Université Libre de Bruxelles at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

CIPS (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in